Hisamitsu Pharmaceutical Co., Inc.

TSE:4530.T

4373 (JPY) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q1
Revenue 39,64635,81038,87935,85034,88132,09636,44932,26233,22626,39333,53028,11230,79027,76133,68827,89628,04424,88241,91435,67734,16829,23340,83433,19035,88533,49938,31736,09037,38236,08136,19635,28236,29438,15339,56939,85542,74839,68041,80337,88839,29637,75635,50637,74740,31737,06535,41535,42537,26234,67034,02134,61236,12033,03934,60031,50438,20932,86931,45633,57634,47230,328
Cost of Revenue 16,04215,00518,50815,89714,95213,37816,53013,94413,50911,64715,24211,76411,95811,16215,18910,5719,9059,67218,83411,66211,99110,90116,55212,04512,53013,60015,42112,68313,58014,00414,37712,58512,65413,53915,88813,16314,75614,51216,10913,05313,97013,93114,35913,09414,17713,84113,30112,34513,48112,53212,19711,54012,10910,93812,52710,75712,97211,44011,07810,82110,9559,803
Gross Profit 23,60420,80520,37119,95319,92918,71819,91918,31819,71714,74618,28816,34818,83216,59918,49917,32518,13915,21023,08024,01522,17718,33224,28221,14523,35519,89922,89623,40723,80222,07721,81922,69723,64024,61423,68126,69227,99225,16825,69424,83525,32623,82521,14724,65326,14023,22422,11423,08023,78122,13821,82423,07224,01122,10122,07320,74725,23721,42920,37822,75523,51720,525
Gross Profit Ratio 0.5950.5810.5240.5570.5710.5830.5460.5680.5930.5590.5450.5820.6120.5980.5490.6210.6470.6110.5510.6730.6490.6270.5950.6370.6510.5940.5980.6490.6370.6120.6030.6430.6510.6450.5980.670.6550.6340.6150.6550.6440.6310.5960.6530.6480.6270.6240.6520.6380.6390.6410.6670.6650.6690.6380.6590.660.6520.6480.6780.6820.677
Reseach & Development Expenses 2,7522,3542,5721,9022,2601,8802,6112,2392,4292,50610,6132,4442,4252,58610,76600010,50400013,03200015,07600014,37800014,96500013,71800013,92400012,662000000000000000
General & Administrative Expenses 00-14,998000-13,882000-24,223000-22,348000-23,234000-24,293000-24,733000-23,887000-27,113000-28,048000-24,16900084000000000000000
Selling & Marketing Expenses 0031,89900028,09600029,53500027,53200031,49900029,20400026,89500026,08800030,35500034,18900029,88300028,325000000000000000
SG&A 17,70114,30116,90114,17813,63414,35614,21412,48612,89514,2255,31215,08215,24411,8935,18414,71813,70114,1328,26515,78714,76715,5524,91116,43416,48115,5432,16215,34916,26216,9872,20113,57716,50818,8703,24217,87719,22019,4306,14119,55319,56119,2345,71418,62918,74818,1524,18315,55700000000000000
Other Expenses 18,7473028890105215-1141308695237-2322181323-27704849711031079696113771336341021446824491791097588831921771079716661166116-2242473071401592142431261092042803,137239116310209
Operating Expenses 18,74716,65519,47316,08015,89414,35616,82514,72515,32414,22515,92515,08215,24414,47915,95014,71813,70114,13218,76915,78714,76715,55217,94316,43416,48115,54317,23815,34916,26216,98717,50913,57716,50818,87019,27517,87719,22019,43020,80519,55319,56119,23420,51118,62918,74818,15217,56015,55715,84416,82516,71415,45817,59615,30116,21914,17516,15114,74616,80313,33615,08013,373
Operating Income 4,8574,1508983,8744,0354,3613,0933,5934,3945192,3641,2673,5862,1202,5482,6074,4381,0784,3108,2277,4122,7786,3374,7126,8754,3545,6588,0587,5395,0904,3119,1207,1315,7444,4068,8158,7725,7374,8905,2825,7654,5906366,0257,3915,0714,5537,5257,9355,3135,1107,6136,4136,8005,8536,5719,0866,6823,5759,4188,4377,151
Operating Income Ratio 0.1230.1160.0230.1080.1160.1360.0850.1110.1320.020.0710.0450.1160.0760.0760.0930.1580.0430.1030.2310.2170.0950.1550.1420.1920.130.1480.2230.2020.1410.1190.2580.1960.1510.1110.2210.2050.1450.1170.1390.1470.1220.0180.160.1830.1370.1290.2120.2130.1530.150.220.1780.2060.1690.2090.2380.2030.1140.280.2450.236
Total Other Income Expenses Net 1,3292,7651,6291,1471,8911,349-95012,1431,8761,601558951,3651,385141659-6603262,654364831,71468889894-4891,112387338-1,3574,099-1791,1157725189-991,0552,6073,1692,0582,5372,6812,6576,7291,8492,0411,8569192,1204,9311,000-1,6111,2271,5641,3013,8161,2251,577240222
Income Before Tax 6,1866,9152,5275,0215,9265,7123,0844,0946,5372,3983,9641,8243,6833,4853,9342,7485,0974184,63710,8817,7752,8628,0525,4007,7724,4495,1709,1707,9265,4282,95313,2196,9536,8594,4838,8408,9605,6395,9447,8908,9336,6493,1738,70510,04811,8016,4029,5649,7936,2327,23012,5457,4155,1897,0818,13610,38710,4994,80010,9968,6777,374
Income Before Tax Ratio 0.1560.1930.0650.140.170.1780.0850.1270.1970.0910.1180.0650.120.1260.1170.0990.1820.0170.1110.3050.2280.0980.1970.1630.2170.1330.1350.2540.2120.150.0820.3750.1920.180.1130.2220.210.1420.1420.2080.2270.1760.0890.2310.2490.3180.1810.270.2630.180.2130.3620.2050.1570.2050.2580.2720.3190.1530.3270.2520.243
Income Tax Expense 1,7561,9445751,2121,4341,5337799931,5586575295429721,0503557071,3683341,3232,9662,0688872,1811,1961,9869311,8892,6692,1371,6728924,1302,1482,2732,0082,9153,0761,9941,6112,9553,3062,5599793,1653,8174,2052,9253,8694,0582,5573,4634,9583,0752,2592,8353,4344,3584,3472,4164,4313,4932,942
Net Income 4,3104,7881,8593,6934,3684,0492,2203,0184,8731,6313,4401,2162,6402,3623,5282,0293,5801133,2747,8725,6351,9135,8754,1715,7063,4523,2796,4545,7123,6742,0559,0544,7574,5292,4665,9425,8413,5354,3084,9025,5763,9982,1695,5076,1677,5143,7885,6875,7213,6133,7707,5814,3292,7584,2874,6675,9176,0852,3246,5305,1724,396
Net Income Ratio 0.1090.1340.0480.1030.1250.1260.0610.0940.1470.0620.1030.0430.0860.0850.1050.0730.1280.0050.0780.2210.1650.0650.1440.1260.1590.1030.0860.1790.1530.1020.0570.2570.1310.1190.0620.1490.1370.0890.1030.1290.1420.1060.0610.1460.1530.2030.1070.1610.1540.1040.1110.2190.120.0830.1240.1480.1550.1850.0740.1940.150.145
EPS 61.3563.8924.5448.5256.2552.0828.3937.8861.1120.4543.0414.9432.2928.943.1624.8243.841.3940.0996.3968.1723.1571.0750.4668.241.2739.1977.1468.2743.9224.56108.2256.1953.529.1370.1868.1841.2750.2957.2265.0946.6825.3264.2871.9987.7144.2266.3866.7842.1844.0188.4950.5432.1149.4653.8568.2770.2126.8173.6458.3349.58
EPS Diluted 61.2863.8124.5448.4256.1952.0428.3937.8561.0420.4543.0414.9332.2728.8943.1624.8243.841.3940.0996.3968.1723.1371.0750.4668.241.2339.1977.1468.2743.8924.56108.2256.1953.4829.1370.1868.1841.2750.2957.2265.0946.6825.3264.2871.9987.7144.2266.3866.7842.1844.0188.4950.5432.1149.4653.8568.2770.2126.8173.6458.3349.58
EBITDA 6,1985,5632,3525,0265,9825,7123,0504,1416,5762,2983,9801,8343,9862,8574,1492,4135,1024195,7159,2827,7832,8667,2365,4107,5674,4516,2099,1847,9374,9475,30310,3427,0035,5704,5498,8548,9685,6705,8607,0748,9246,6663,4058,66610,1436,7306,9979,5859,8726,63510,13911,3709,9748,9999,0989,97312,40512,0347,68011,90610,9438,432
EBITDA Ratio 0.1560.1550.060.140.1710.1780.0840.1280.1980.0870.1190.0650.1290.1030.1230.0860.1820.0170.1360.260.2280.0980.1770.1630.2110.1330.1620.2540.2120.1370.1470.2930.1930.1460.1150.2220.210.1430.140.1870.2270.1770.0960.230.2520.1820.1980.2710.2650.1910.2980.3280.2760.2720.2630.3170.3250.3660.2440.3550.3170.278